The brains in Spain fall mainly on…Iran?

braininjWe’ve come across some odd examples of plagiarism in this job, from the fellow who tried to build a CV on the back of another researcher’s work, to the education researcher who, from what we can tell, preferred lifting the work of others to writing her own papers. Here’s another odd one for the pile.

A group of Iranian scholars has lost a paper in Brain Injury because they lifted it wholesale from a previously published article. What’s harder to get one’s mind around, however, is that the two papers were looking at culturally-specific aspects of brain injury. Except that one wasn’t.

The retracted paper, “Frontal acquired brain injury, substance abuse and their common psychological symptoms in the Iranian population,” appeared in 2011. Here’s the abstract, which is still available on the journal’s website (we’ll note that although the abstract is free for all, the retraction notice was behind a pay wall — an error, according to the publisher, which they remedied when we contacted them):  Continue reading The brains in Spain fall mainly on…Iran?

Lacking “scientific and analytical rigor,” 8-year-old lymphoma paper falls to retraction

leuklympjuly13Leukemia & Lymphoma has retracted 2004 paper by a group of authors in Mexico after concluding that, well, the article never should have been accepted to begin with.

The article, “Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome,” came from oncologists at the National Medical Center. Its abstract (still available on Medline) states: Continue reading Lacking “scientific and analytical rigor,” 8-year-old lymphoma paper falls to retraction

Don’t feel so bad, The Aging Male: It happens to lots of journals

aging maleThe Aging Male (the journal, not the demographic) is retracting a 2013 paper by a group of Chinese researchers who’d published the same work — more or less — in a Chinese title.

The article, “Testosterone therapy improves psychological distress and health-related quality of life in Chinese men with symptomatic late-onset hypogonadism patients,” came from a group at Peking University People’s Hospital, in Beijing.

But as the retraction notice explains: Continue reading Don’t feel so bad, The Aging Male: It happens to lots of journals

Purloined dissertation on stroke ends in retraction for Iranian group

intjneursciThe International Journal of Neuroscience, an Informa Healthcare journal, has retracted a paper it published earlier this year after learning that the article was the doctoral work of another scientist — not listed among the authors — that had appeared previously in a Persian-language journal.

The retraction notice, admirably thorough, explains what happened with the paper:

Duplicate publication of headache paper earns Expression of Concern, erratum

eottA 2003 paper is now subject to an Expression of Concern after its author reused a lot of its material in a 2007 paper.

Here’s the Expression of Concern for “New therapeutic target in primary headaches – blocking the CGRP receptor” by Lars Edvinsson of the University of Copehagen: Continue reading Duplicate publication of headache paper earns Expression of Concern, erratum

Error scuppers paper on treatment for liver fibrosis

pharmbioPharmaceutical Biology has retracted a 2012 paper by a group of liver researchers from China after the discovery of an error that evidently invalidated the results in the paper.

The article, “Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis,” purported to show that

protocatechuic aldehyde, the major degradation of phenolic acids … has potentially conferring antifibrogenic effects.

In other words, the compound appears to prevent the formation of liver fibroids.
But it doesn’t — at least, not according to the study — as the retraction notice explains: Continue reading Error scuppers paper on treatment for liver fibrosis

Double dipping on exercise/cardiac risk paper leads to retraction

intjneurosciThe International Journal of Neuroscience has retracted a September 2005 paper by a group from Turkey who published the same article in the same month in a different journal.

The research involved looking at concentrations of blood fats in athletes and less vigorous folk, “and to examine the risks of cardiovascular diseases.”It found that:

… medium and high level of exercises did not cause significant differences in lipid and lipoprotein levels, but the sex differences were very pronounced” with “lipid and lipoprotein profile of female subjects was found to be better than that of males”.

Here’s the notice: Continue reading Double dipping on exercise/cardiac risk paper leads to retraction

Smoking cessation paper pulled for “almost word-for-word” similarity to authors’ previous work

jmfnmThe Journal of Maternal-Fetal & Neonatal Medicine has retracted a 2008 article on smoking cessation by a group from Sweden which they had published not many months before in a different journal.

The retracted paper was titled “Quitting smoking is perceived to have an effect on somatic health among pregnant and non-pregnant women.” The authors, from the Royal Institute of Technology in Stockholm, had published a similar paper — “Perception of Smoking-Related Health Consequences among Pregnant and Non-Pregnant Women” — in the American Journal of Addictions in 2007.

How similar?

Continue reading Smoking cessation paper pulled for “almost word-for-word” similarity to authors’ previous work

Duplication leads to retraction of 1997 paper on heart disease genes

crit rev clin lab sciA top cardiology researcher, Robert Hegele, of the Robarts Research Institute at the University of Western Ontario, has retracted a 15-year-old review after editors were made aware that it was “very similar” to another of his reviews.

Here’s the December 2012 notice for the paper, which has been cited 23 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Duplication leads to retraction of 1997 paper on heart disease genes

Retraction for prostate cancer paper duplication leaves authors penitent, “happy”

Perhaps fittingly in today’s age of sensitive feelings, the typical reaction to a retraction (per the notices, at least) is apology. But bliss?

Expert Opinion on Investigational Drugs has a new one in the annals of penitence. At issue is a 2010 paper titled “Horizon scanning for novel therapeutics for the treatment of prostate cancer,” by Dieletta Bianchini. Turns out the authors had published the same (or nearly so) paper two months earlier in a different journal. Here’s the notice: Continue reading Retraction for prostate cancer paper duplication leaves authors penitent, “happy”